rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses

Bibliographic Details
Main Authors: Bart P, Huang Y, Frahm N, Karuna S, Allen M, Kochar NK, Chappuis S, Gaillard J, Graham B, Pantaleo G
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Retrovirology